ADVFN ADVFN

Hot Features

Icon for default Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
TriSalus Life Sciences Inc

TriSalus Life Sciences Inc (TLSI)

3,17
-0,13
(-3,94%)
Fermé 06 Juin 10:00PM
3,17
0,00
(0,00%)
Après les heures de négociation: 12:32AM

TriSalus Life Sciences Inc (TLSI) Action

Votre Hub pour des idées et discussions en direct en temps réel

Premium

Statistiques et détails clés

Dernier
3,17
( -3,94% )
Prix Achat
3,16
Prix Vente
3,50
Volume échangé
304 401
3,16 Fourchette du Jour 3,33
2,20 Plage de 52 semaines 7,95
Cap du marché
Clôture Veille
3,30
Ouverture
3,29
Dernière Transaction
2
@
3.27
Dernière heure de transaction
Volume financier
US$ 985 621
VWAP
3,2379
Volume moyen (3 m)
US$ 364 941
Actions en circulation
61 416 535
Rendement du Dividende (LTM)
Ratio Cours sur Bénéfices
-2,62
Bénéfice par action (BPA)
-1,3
Chiffre d'affairess (LTM)
44,88M
Bénéfice net (LTM)
-27,31M

À propos de TriSalus Life Sciences Inc

TriSalus Life Sciences, Inc. engages in the research, development, and commercialization of drug delivery technology platform and immuno-oncology therapeutics to improve outcomes for patients with difficult-to-treat liver and pancreatic cancers in the United States. It offers Pressure-Enabled Drug D... TriSalus Life Sciences, Inc. engages in the research, development, and commercialization of drug delivery technology platform and immuno-oncology therapeutics to improve outcomes for patients with difficult-to-treat liver and pancreatic cancers in the United States. It offers Pressure-Enabled Drug Delivery (PEDD) infusion systems, such as the TriNav infusion system, which is used in transarterial radioembolization and chemoembolization procedures for patients with liver cancer and metastases; and the Pancreatic Retrograde Venous Infusion device, which is in Phase 1 clinical trial for treating locally advanced pancreatic cancer. The company is also developing nelitolimod, an investigational immunotherapeutic in Phase 1 clinical trial for the treatment of uveal melanoma, intrahepatic cholangiocarcinoma, hepatocellular carcinoma, and pancreatic cancer. It serves interventional radiologists, IR technicians, medical oncologists, nursing support, and value analysis committee staff. The company was founded in 2009 and is headquartered in Westminster, Colorado. Show more

Secteur
Healthcare
Industrie
Medical Equipment & Supplies
Siège social
Westminster, United States
Fondé
2026
TriSalus Life Sciences Inc est coté dans le secteur Healthcare de la NASDAQ avec le ticker TLSI. Le dernier cours de clôture d'TriSalus Life Sciences était de US$3,30. Au cours de la dernière année, les actions de TriSalus Life Sciences ont été négociées dans une fourchette de prix de US$ 2,20 à US$ 7,95.

TriSalus Life Sciences compte actuellement 61 416 535 actions en circulation. La capitalisation boursière d'TriSalus Life Sciences est de US$194,69 million. TriSalus Life Sciences a un ratio cours/bénéfice (ratio PE) de -2.62.

TLSI Dernières nouvelles

PériodeVariationVariation %Ouver.HautBasMoyenne Vol. Quot.VWAP
1-0.08-2.461538461543.253.683.05042582173.3988764CS
4-1.25-28.28054298644.424.732.28259212.87059682CS
12-0.96-23.24455205814.134.84992.23710353.2225366CS
26-3.615-53.27929255716.7857.952.22738164.1789934CS
52-1.94-37.96477495115.117.952.21950584.43402233CS
156-10.63-77.028985507213.816.242.2995265.01164798CS
260-10.63-77.028985507213.816.242.2995265.01164798CS

TLSI - Frequently Asked Questions (FAQ)

What is the current TriSalus Life Sciences Inc share price?
The current share price of TriSalus Life Sciences Inc is US$ 3,17
How many TriSalus Life Sciences Inc shares are in issue?
TriSalus Life Sciences Inc has 61 416 535 shares in issue
What is the market cap of TriSalus Life Sciences Inc?
The market capitalisation of TriSalus Life Sciences Inc is USD 194,69M
What is the 1 year trading range for TriSalus Life Sciences Inc share price?
TriSalus Life Sciences Inc has traded in the range of US$ 2,20 to US$ 7,95 during the past year
What is the PE ratio of TriSalus Life Sciences Inc?
The price to earnings ratio of TriSalus Life Sciences Inc is -2,62
What is the cash to sales ratio of TriSalus Life Sciences Inc?
The cash to sales ratio of TriSalus Life Sciences Inc is 4,67
What is the registered address of TriSalus Life Sciences Inc?
The registered address for TriSalus Life Sciences Inc is 6272 West 91st Avenue, Westminster, Colorado, 80031
What is the TriSalus Life Sciences Inc website address?
The website address for TriSalus Life Sciences Inc is trisaluslifesci.com
Which industry sector does TriSalus Life Sciences Inc operate in?
TriSalus Life Sciences Inc operates in the Medical Equipment & Supplies sector

TLSI Transactions

Plus

Transactions différées

Pour obtenir des transactions en temps réel, améliorez votre compte

Passer à la version en temps réel
Aucune Discussion Trouvée
Ajouter une Discussion

Dernières Valeurs Consultées

Delayed Upgrade Clock